Researchers have identified a new compound, CT51, that can potentially protect neurons from damage in severe neurodegenerative diseases, such as Friedreich’s ataxia. It can also be used to detect iron inside cells, which could be useful for monitoring these diseases. The study, “Development of an iron-selective antioxidant probe…
The Friedreich’s Ataxia Research Alliance (FARA) and the Critical Path Institute‘s (C-Path) Data Collaboration Center (DCC) will work together to create a database of clinical data for Friedreich’s ataxia (FA). Access to the large-scale database is expected to expedite research on the disease and clinical trials of therapies…
The U.S. Food and Drug Administration (FDA) has awarded a $2 million, five-year grant to Dr. David Lynch of the Children’s Hospital of Philadelphia to study the natural history of Friedrich’s ataxia (FA) and five other rare diseases. The award is part of the FDA’s Orphan Products Grant Program. “We…
Get regular updates to your inbox.